P18-12 LB. Phase I clinical trial with a new recombinant MVA-BN®-multiantigen vaccine: high responder rate and considerable breadth of immunological response (2009)
Overton, T,
Schmidt, D,
Hain, J,
Virgin, G,
Steigerwald, R,
Dirmeier, U,
...
No abstract available.